Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−1.00 USD
−68.96 M USD
0.00 USD
43.73 M
About PMV Pharmaceuticals, Inc.
Sector
Industry
CEO
David H. Mack
Website
Headquarters
Princeton
Founded
2013
FIGI
BBG007NM47G3
PMV Pharmaceuticals, Inc. is a precision oncology company, which engages in the discovery and development of small molecule, tumor-agnostic therapies targeting p53. The company was founded by Arnold J. Levine, David Henry Mac, and Thomas E. Shenk in March 2013 and is headquartered in Princeton, NJ.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of PMVP is 1.61 USD — it has decreased by −1.26% in the past 24 hours. Watch PMV Pharmaceuticals, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange PMV Pharmaceuticals, Inc. stocks are traded under the ticker PMVP.
PMVP stock has fallen by −6.55% compared to the previous week, the month change is a −0.63% fall, over the last year PMV Pharmaceuticals, Inc. has showed a −28.76% decrease.
We've gathered analysts' opinions on PMV Pharmaceuticals, Inc. future price: according to them, PMVP price has a max estimate of 18.00 USD and a min estimate of 5.00 USD. Watch PMVP chart and read a more detailed PMV Pharmaceuticals, Inc. stock forecast: see what analysts think of PMV Pharmaceuticals, Inc. and suggest that you do with its stocks.
PMVP reached its all-time high on Jan 4, 2021 with the price of 63.22 USD, and its all-time low was 1.18 USD and was reached on Oct 27, 2023. View more price dynamics on PMVP chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
PMVP stock is 5.77% volatile and has beta coefficient of 1.24. Track PMV Pharmaceuticals, Inc. stock price on the chart and check out the list of the most volatile stocks — is PMV Pharmaceuticals, Inc. there?
Today PMV Pharmaceuticals, Inc. has the market capitalization of 81.24 M, it has decreased by −1.87% over the last week.
Yes, you can track PMV Pharmaceuticals, Inc. financials in yearly and quarterly reports right on TradingView.
PMV Pharmaceuticals, Inc. is going to release the next earnings report on Feb 26, 2025. Keep track of upcoming events with our Earnings Calendar.
PMVP earnings for the last quarter are −0.37 USD per share, whereas the estimation was −0.35 USD resulting in a −7.02% surprise. The estimated earnings for the next quarter are −0.36 USD per share. See more details about PMV Pharmaceuticals, Inc. earnings.
PMV Pharmaceuticals, Inc. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
PMVP net income for the last quarter is −19.23 M USD, while the quarter before that showed −1.21 M USD of net income which accounts for −1.48 K% change. Track more PMV Pharmaceuticals, Inc. financial stats to get the full picture.
No, PMVP doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 21, 2024, the company has 63.00 employees. See our rating of the largest employees — is PMV Pharmaceuticals, Inc. on this list?
Like other stocks, PMVP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PMV Pharmaceuticals, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PMV Pharmaceuticals, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PMV Pharmaceuticals, Inc. stock shows the sell signal. See more of PMV Pharmaceuticals, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.